Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Investigating the Safety of srTMS in the Treatment of Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety of srTMS for Parkinson disease has completed, sponsored by the National Institute of Neurological Disorders and S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED